Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
Moosa Abdur Raqib,1 Abdul Haseeb,2 Muhammad Ashir Shafique,2 Tagwa Kalool Fadlalla Ahmed,3 Muhammad Saqlain Mustafa2 1Department of Medicine, Liaquat College of Medicine & Dentistry, Karachi, Sindh, Pakistan; 2Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan; 3De...
Saved in:
Main Authors: | Abdur Raqib M (Author), Haseeb A (Author), Shafique MA (Author), Fadlalla Ahmed TK (Author), Mustafa MS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX
by: Michael Z. Liao, et al.
Published: (2023) -
Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin
by: Rupam Sharma MD, et al.
Published: (2024) -
Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma
by: Dan Lu, et al.
Published: (2020) -
Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017) -
Primary diffuse large B-cell lymphoma of the mandible
by: Juliana Mota Siqueira, et al.
Published: (2019)